Skip to main content
. 2013 Mar 26;22(9):1921–1935. doi: 10.1007/s00586-013-2739-z

Table 2.

Characteristics of studies comparing biological agents with alternative interventions

Study Participants Intervention Control treatment Length of follow-up Outcomes
Biological agents vs. epidural steroid injection
 Becker et al. [19] Germany, RCT 84 patients with nerve root pain confirmed by imaging for at least 6 weeks; Mean age 54 years; 62 % men Epidural injection of autologous conditioned serum (Group 1) Epidural injection of steroid triamcinolone 5 mg or 10 mg + local anaesthetic 1 ml (Groups 2 and 3) 22 weeks Overall pain intensity (VAS)a; Oswestry Disability Index, adverse effects [Results from groups 2 & 3 combined for the forest plot]
 Cohen et al. [26] USA, Germany, RCT 84 patients with nerve root pain confirmed by imaging; mean duration 2.7 months; mean age 42 years; 70 % men Transforaminal epidural injection etanercept 4 mg Transforaminal epidural injection of steroid methyl prednisolone 60 mg + local anaesthetic 0.5 ml 6 months (large proportion left study after 1 month)b Global perceived effect; back and leg pain intensity (NRS); Oswestry Disability Index; reduction in analgesic consumption
Biological agents vs. intravenous steroid
 Genevay et al. [29] Switzerland, HCS 20 patients with nerve root pain confirmed by imaging; mean duration 3.2 weeks; Mean age 47 years; 50 % men Subcutaneous injection of etanercept 25 mg (anti-TNF alpha) ×3 Intravenous injection of methylprednisolone 250 mg ×3 6 weeks Numbers with a good clinical result (leg pain VAS < 30 or Oswestry Disability Index < 20); back and leg pain intensity (VAS); Oswestry Disability Index; Roland-Morris Questionnaire; number of discectomies

HCS historical cohort study, RCT randomised controlled trial, TNF tumour necrosis factor, VAS visual analogue scale

aResults extracted from graphs

bAfter 1 month participants who received no benefit exited the study to pursue other treatments